Trial NCT03628053

View at ClinicalTrials.gov 
Org. Study IDs: CCTL019I2301

Last trial update was posted on 2020-07-09

MeSH Interventions

Blinatumomab Inotuzumab Ozogamicin Tisagenlecleucel

MeSH Conditions

Leukemia Leukemia, Lymphoid Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions

Acute Lymphoblastic Leukemia

Stopping Reasons

Novartis is no longer pursuing this study because of planned investigation of novel CAR-T therapies in this patient population.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID